App-Quantinova.ai

LONG-TERM ANTICOAGULANT TREATMENT OF SPLANCHNIC VENOUS THROMBOSIS IN HIGH RISK PATIENTS: DIRECT ORAL ANTICOAGULANTS VS VITAMIN K ANTAGONISTS

Alessandra Serrao - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ENDOTHELIUM-BIOMARKERS FOR POST-THROMBOTIC SYNDROME: A CASE-CONTROL STUDY.

Sabrina Ranero - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

ICAM-1

THE RISK OF PULMONARY EMBOLISM DEVELOPMENT IN YOUNG PATIENTS WITH VENOUS THROMBOEMBOLISM COULD DEPEND ON 'GENE-GENE INTERACTION' BETWEEN PAI-1 - 675 4G/5G AND TNF-A -308 G/A POLYMORPHISMS

Sergey Kapustin - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) RELATED THROMBOSIS IN HEMATOLOGICAL MALIGNANCIES: A DECADE OF EXPERIENCE IN A SINGLE SPANISH CENTER

Marta Fonseca - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

NOVEL MUTATIONS IN TWO CHINESE FAMILIES WITH INHERITED PROTEIN S DEFICIENCY

Yi FANG - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

RETROSPECTIVE COHORT OF LUPUS ANTICOAGULANT (LA) POSITIVE PATIENTS: ANALYSIS ACCORDING TO THE PRESENCE OF ANTIPHOSPHOLIPID SYNDROME (APS), EXTRA CRITERIA OR NO SYMPTOMS

Veronica Privitera - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

CANCER-ASSOCIATED THROMBOSIS: PATTERN OF MANAGEMENT AND LONG-TERM OUTCOMES; SINGLE CENTRE EXPERIENCE

Muteb Althomali - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

PEDIATRIC THROMBOSIS: A RETROSPECTIVE ANALYSIS OF THE INCIDENCE, CHARACTERISTICS AND RISK FACTORS IN A SPANISH CENTER.

Irene Snchez Bazn - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

OUTCOME OF CHILDREN WITH PORTAL VENOUS THROMBOSIS

Selin Aytac - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

TROMBOFILIA STUDY IN PROVOCATED TROMBOEMBOLIC DISEASE

Bianca Daz Roldn - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

SEIZURE AS A RARE SIDE EFFECT OF L-ASPARAGINASE INFUSION IN A LEUKEMIC CHILD WITH DOWN SYNDROME

Veysel GOK - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Methylprednisolone

PREDICTORS OF EARLY DEATH IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

Nikica Sabljic - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Fibrinogen (IV)

СLINICAL CASE OF THE DEVELOPMENT OF NON-HODGKIN'S LYMPHOMA IN A PATIENT WITH ESSENTIAL THROMBOCYTHEMIA

Maria Mikhaleva - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Adcetris

ACCIDENTLY DISCOVERED FEMALE WITH COMBINED FACTOR XI AND XII DEFICIENCY.

Noha Eisa - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

POST-TRANSPLANTATION ERYTHROCYTOSIS IN KIDNEY TRANSPLANT RECIPIENTS- A RETROSPECTIVE COHORT STUDY

Liron Hofstetter - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

USE OF DIRECT ORAL ANTICOAGULANTS AS PRIMARY OR SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH MULTIPLE MYELOMA ON IMMUNOMODULATORY DRUGS

Carlos Aguilar - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

rivaroxaban

CHRONIC KIDNEY DISEASE COULD BE A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA

Ivan Krecak - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

PLATELET AND COAGULATIVE ABNORMALITIES IN POLYCYTHEMIA VERA PATIENTS: THROMBOTIC RISK

EMMA CACCIOLA - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

OUTCOMES IN PV AND ET ARE AFFECTED BY AGE, THROMBOSIS, JAK2 STATUS AND SECOND CANCERS: LONG-TERM FOLLOW-UP FROM A DISTRICT GENERAL HOSPITAL.

Luke Attwell - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

ECULIZUMAB IN THE TREATMENT OF HYPERHAEMOLYSIS IN PATIENTS WITH SICKLE CELL DISEASE; A SINGE CENTRE EXPERIENCE

Monica Ragheb - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Hydroxycarbamide

Filters

7277 Abstracts